BIOCRYST PHARMACEUTICALS, INC.
Net Cash Flow Breakdown
Total Cash from Operations: $350.3M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $0 | 0.0% |
| Other Investing | $0 | 0.0% |
| Other Financing | $334.3M | 95.4% |
| Working Capital | $2.9M | 0.8% |
| Other | $13.1M | 3.7% |
| Net Cash Flow | $0 | 0.0% |